Detalles de la búsqueda
1.
Artemisinin disrupts androgen responsiveness of human prostate cancer cells by stimulating the 26S proteasome-mediated degradation of the androgen receptor protein.
Anticancer Drugs
; 28(9): 1018-1031, 2017 10.
Artículo
en Inglés
| MEDLINE | ID: mdl-28708672
2.
Essential role of the cancer stem/progenitor cell marker nucleostemin for indole-3-carbinol anti-proliferative responsiveness in human breast cancer cells.
BMC Biol
; 12: 72, 2014 Sep 12.
Artículo
en Inglés
| MEDLINE | ID: mdl-25209720
3.
Antiproliferative effects of artemisinin on human breast cancer cells requires the downregulated expression of the E2F1 transcription factor and loss of E2F1-target cell cycle genes.
Anticancer Drugs
; 23(4): 370-9, 2012 Apr.
Artículo
en Inglés
| MEDLINE | ID: mdl-22185819
4.
Indole-3-carbinol downregulation of telomerase gene expression requires the inhibition of estrogen receptor-alpha and Sp1 transcription factor interactions within the hTERT promoter and mediates the G1 cell cycle arrest of human breast cancer cells.
Carcinogenesis
; 32(9): 1315-23, 2011 Sep.
Artículo
en Inglés
| MEDLINE | ID: mdl-21693539
5.
Arecoline induced disruption of expression and localization of the tight junctional protein ZO-1 is dependent on the HER 2 expression in human endometrial Ishikawa cells.
BMC Cell Biol
; 11: 53, 2010 Jul 06.
Artículo
en Inglés
| MEDLINE | ID: mdl-20604955
6.
Anticancer activities of artemisinin and its bioactive derivatives.
Expert Rev Mol Med
; 11: e32, 2009 Oct 30.
Artículo
en Inglés
| MEDLINE | ID: mdl-19883518
7.
Artemisinin selectively decreases functional levels of estrogen receptor-alpha and ablates estrogen-induced proliferation in human breast cancer cells.
Carcinogenesis
; 29(12): 2252-8, 2008 Dec.
Artículo
en Inglés
| MEDLINE | ID: mdl-18784357
8.
Indole-3-carbinol selectively uncouples expression and activity of estrogen receptor subtypes in human breast cancer cells.
Mol Endocrinol
; 20(12): 3070-82, 2006 Dec.
Artículo
en Inglés
| MEDLINE | ID: mdl-16901971
9.
Indole-3-carbinol disrupts estrogen receptor-alpha dependent expression of insulin-like growth factor-1 receptor and insulin receptor substrate-1 and proliferation of human breast cancer cells.
Mol Cell Endocrinol
; 363(1-2): 74-84, 2012 Nov 05.
Artículo
en Inglés
| MEDLINE | ID: mdl-22835548
10.
BZL101, a phytochemical extract from the Scutellaria barbata plant, disrupts proliferation of human breast and prostate cancer cells through distinct mechanisms dependent on the cancer cell phenotype.
Cancer Biol Ther
; 10(4): 397-405, 2010 Aug 15.
Artículo
en Inglés
| MEDLINE | ID: mdl-20574166
11.
Indole-3-carbinol triggers aryl hydrocarbon receptor-dependent estrogen receptor (ER)alpha protein degradation in breast cancer cells disrupting an ERalpha-GATA3 transcriptional cross-regulatory loop.
Mol Biol Cell
; 21(7): 1166-77, 2010 Apr 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-20130088
12.
1-Benzyl-indole-3-carbinol is a novel indole-3-carbinol derivative with significantly enhanced potency of anti-proliferative and anti-estrogenic properties in human breast cancer cells.
Chem Biol Interact
; 186(3): 255-66, 2010 Aug 05.
Artículo
en Inglés
| MEDLINE | ID: mdl-20570586
13.
Minireview: modulation of hormone receptor signaling by dietary anticancer indoles.
Mol Endocrinol
; 23(12): 1940-7, 2009 Dec.
Artículo
en Inglés
| MEDLINE | ID: mdl-19837944
14.
Artemisinin blocks prostate cancer growth and cell cycle progression by disrupting Sp1 interactions with the cyclin-dependent kinase-4 (CDK4) promoter and inhibiting CDK4 gene expression.
J Biol Chem
; 284(4): 2203-13, 2009 Jan 23.
Artículo
en Inglés
| MEDLINE | ID: mdl-19017637
Resultados
1 -
14
de 14
1
Próxima >
>>